Health Economics

1,216 Results

number of items to display at a time

Commentary

Apr 23, 2025

Redesigning Health Care Plans to Lower Costs

Employers and employees can use their health insurance benefit designs to make health care more affordable, and without the need for further taxpayer subsidies, by designing tiered networks of providers who are responsible for meeting specific total cost of care benchmarks.
Research

Dec 18, 2024

Methods of Assessing Duplication of Benefits with Patient Care Revenue: As Applied by the Federal Emergency Management Agency to Health Care Providers' Public Assistance Claims During the COVID-19 Emergency

Researchers developed analytic methods and subsequent guidance to identify duplication of benefits with patient care revenue in Federal Emergency Management Agency Public Assistance applications and reviewed select applications for such duplication.
Research

Dec 10, 2024

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

The lack of transparency of prices in the U.S. health care market limits employers' ability to knowledgeably develop or implement benefit design decisions. This report presents a metric that can be used to compare hospital prices.
Nov 13, 2024

Benefits and Affordability

RAND Health Care research addressing health care benefits and affordability.
Nov 13, 2024

Price Transparency

RAND Health Care research on price transparency in the health care environment, including work on topics such as Accountable Care Organizations, bundled payment, medical homes and value based purchasing.
Project

Sep 26, 2024

The economic impacts of antimicrobial resistance in livestock (EcoAMR)

RAND Europe researchers are modelling the economic impact of antimicrobial resistance in livestock.
Research

Aug 14, 2024

The burden of respiratory syncytial virus in adults in the UK

This study describes and quantifies the burden of respiratory syncytial virus (RSV) in the United Kingdom in adults to the patients, the health and care systems and the economy. The total economic cost is estimated to be around £319m annually.
Research

Jul 5, 2024

Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

This study examines who pays for health care under rate regulation, spending growth target, and single-payer health care polices. We used microsimulation to estimate household health care payments (out-of-pocket costs, premiums, and taxes).
Press

May 13, 2024

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prices paid to hospitals during 2022 by employers and private insurers for both inpatient and outpatient services averaged 254 percent of what Medicare would have paid, with wide variation in prices among states.
Press

Feb 1, 2024

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Prescription drug prices in the United States are significantly higher than in other nations, with prices in the United States averaging 2.78 times those seen in 33 other nations.
Press

Feb 1, 2024

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

The gross price of insulin in the United States is more than nine times higher than in 33 high-income comparison nations.
Press

Feb 1, 2024

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Most new prescription drugs are sold first in the United States before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a year of first sale.

Health Economics

Health Economics

How Do U.S. Insulin Prices Compare to Those in Other Countries?

Explore RAND’s Work on this Topic

Error

Redesigning Health Care Plans to Lower Costs

Methods of Assessing Duplication of Benefits with Patient Care Revenue: As Applied by the Federal Emergency Management Agency to Health Care Providers' Public Assistance Claims During the COVID-19 Emergency

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

Benefits and Affordability

Price Transparency

The economic impacts of antimicrobial resistance in livestock (EcoAMR)

The burden of respiratory syncytial virus in adults in the UK

Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Oops! An unexpected error has occurred.

RAND Headquarters

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Health Economics

Health Economics

How Do U.S. Insulin Prices Compare to Those in Other Countries?

Explore RAND’s Work on this Topic

Error

Redesigning Health Care Plans to Lower Costs

Methods of Assessing Duplication of Benefits with Patient Care Revenue: As Applied by the Federal Emergency Management Agency to Health Care Providers' Public Assistance Claims During the COVID-19 Emergency

Prices Paid to Hospitals by Private Health Plans: Findings from Round 5.1 of an Employer-Led Transparency Initiative

Benefits and Affordability

Price Transparency

The economic impacts of antimicrobial resistance in livestock (EcoAMR)

The burden of respiratory syncytial virus in adults in the UK

Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

Private Health Plans During 2022 Paid Hospitals 254 Percent of What Medicare Would Pay

Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries

Insulin Prices Are Sharply Higher in the United States Than in Other Countries

New Prescription Drugs Typically Sold First in U.S., Reach Other Wealthy Nations Within a Year

Oops! An unexpected error has occurred.